We are live on ! Find out more
CNMD icon

CONMED

234 hedge funds and large institutions have $2.8B invested in CONMED in 2019 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 89 increasing their positions, 72 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 72

15% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 27

12% more capital invested

Capital invested by funds: $2.5B → $2.8B (+$301M)

2% more funds holding

Funds holding: 230234 (+4)

0.54% less ownership

Funds ownership: 103.6%103.06% (-0.54%)

13% less call options, than puts

Call options by funds: $5.33M | Put options by funds: $6.13M

Holders
234
Holders Change
+4
Holders Change %
+1.74%
% of All Funds
5.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
31
Increased
89
Reduced
72
Closed
27
Calls
$5.33M
Puts
$6.13M
Net Calls
-$800K
Net Calls Change
-$2.07M

CNMD Hedge Fund Activity: Q3 2019 in Review

234 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q3 2019, worth a combined $2.8B — up 12% from $2.5B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new CNMD positions and 27 closed out — a net gain of 4 holders — while 89 added to existing stakes and 72 trimmed.

The largest buyer was Columbus Circle Investors, opening a new position worth an estimated $24M. The largest seller was Point72 Asset Management, cutting an estimated $62.9M.

  • 234 institutional investors held CONMED (CNMD) as of Q3 2019, up from 230 in Q2 2019.
  • Funds reported $2.8B of CONMED stock for Q3 2019, up 12% quarter-over-quarter.
  • 31 funds opened new CONMED positions in Q3 2019 and 27 closed out, a net change of +4 holders.
  • The largest CONMED buyer in Q3 2019 was Columbus Circle Investors, an estimated $24M added.
  • The largest CONMED seller in Q3 2019 was Point72 Asset Management, an estimated $62.9M sold.

Based on aggregated 13F filings for Q3 2019.